This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Johann Wolfgang Goethe-Universitat Frankfurt Am Main, Migagen Therapeutics, Inc.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2014-2015
Title: Reinier Boon: Innovator in Cardiovascular Research
Introduction
Reinier Boon is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of cardiovascular research, particularly in the development of innovative treatments for aortic aneurysms and age-related cardiomyopathy. With a total of 2 patents, his work is paving the way for advancements in medical therapies.
Latest Patents
Boon's latest patents include "Antagonists of miRNA-29 expression and their use in the prevention and treatment of aneurysm." This invention focuses on antagonists that target the micro RNA miRNA-29, which can be utilized in preventing and treating aortic aneurysms. The patent also outlines methods for identifying these antagonists and developing pharmaceutical compositions for effective treatment.
Another significant patent is "Micro-RNA for the regulation of cardiac apoptosis and contractile function." This invention addresses the treatment and prevention of age-related cardiomyopathy by modulating the expression or activity of a member of the miR-34 family and/or PNUTS. The methods described include administering inhibitors or agonists to improve cardiac health and prevent conditions such as cardiac fibrosis and myocardial infarction.
Career Highlights
Reinier Boon has worked with esteemed institutions, including Johann Wolfgang Goethe-Universität Frankfurt am Main and Migagen Therapeutics, Inc. His research has been instrumental in advancing our understanding of cardiovascular diseases and developing new therapeutic strategies.
Collaborations
Boon has collaborated with notable colleagues such as Andreas Michael Zeiher and Stefanie Dimmeler. These partnerships have enhanced his research efforts and contributed to the success of his innovative projects.
Conclusion
Reinier Boon is a prominent inventor whose work in cardiovascular research is making a significant impact. His patents reflect a commitment to improving medical treatments and advancing scientific knowledge in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile